Health Canada has decided to put on hold a new product licensing requirement under which manufacturers of medical devices with a drug component were required to provide the Drug Identification Number (DIN) of the product’s medicinal component to establish that it meets acceptable standards of safety, efficacy and quality 1...
Please login to read the full article.
